Iyamu, Osahon
Ciccone, Emily J.
Schulz, Abigail
Sung, Julia
Abernathy, Haley
Alejo, Aidin
Tyrlik, Katherine
Arahirwa, Victor
Mansour, Odai
Giandomenico, Dana
Diaz, Monica M.
Boyce, Ross M.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (K23AI173658-01A1)
National Center for Advancing Translational Sciences (UL1TR002489)
UNC Office of the Vice Chancellor for Research
Article History
Received: 20 December 2023
Accepted: 12 July 2024
First Online: 17 July 2024
Declarations
:
: The study was approved by the institutional review board of the University of North Carolina at Chapel Hill (IRB 21–0356). As a limited data set under CFR 45, Part 164.514 (e), written patient consent or waiver of HIPAA authorization was not required as all patient interactions and resulting data were collected solely for non-research purposes.
: The case series did not require individual patient consent through the UNC Institutional Review Board as all patient interactions and resulting data were collected solely for non-research purposes.
: The authors declare no competing interests.